BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld
BioWorld
June 23, 2008
View Archived Issues
Rare Pulmonary Fibrosis may Have Blockbuster Potential
A handful of companies are working to develop a treatment for a rare lung disorder called pulmonary fibrosis that, by some estimates, could present a $500 million to $1.5 billion market opportunity. (BioWorld Financial Watch)
Read More
Money Raised By Month
Read More
Stock Winners and Losers For The Week
Read More
Biotechnology Company Deals With Other Biotechnology Companies: May 16 - June 19, 2008
Read More
Biotechnology Company Deals With Miscellaneous Companies: May 16 - June 19, 2008
Read More
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: May 16 - June 19, 2008
Read More
Biotech -- Biotech Collaborations: Modified Agreements: May 16 - June 19, 2008
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More
